Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT06775379 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Xenon Pharmaceuticals Inc. |
| Last Updated on CT.gov | October 22, 2025 (Oct 22, 2025) |
As of March 2, 2026: Clinical trial NCT06775379 is currently recruiting participants. This clinical trial study for major depressive disorder is actively seeking new participants at 46 locations across the United States. The study is sponsored by Xenon Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06775379 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06775379 was last updated Oct 22, 2025 (October 22, 2025). HelloStudys verifies this status automatically.